495 related articles for article (PubMed ID: 19497438)
1. The scope of coronary heart disease in patients with chronic kidney disease.
Hage FG; Venkataraman R; Zoghbi GJ; Perry GJ; DeMattos AM; Iskandrian AE
J Am Coll Cardiol; 2009 Jun; 53(23):2129-40. PubMed ID: 19497438
[TBL] [Abstract][Full Text] [Related]
2. Heart failure in patients with chronic kidney disease.
Lisowska A; Musiał WJ
Rocz Akad Med Bialymst; 2004; 49():162-5. PubMed ID: 15631334
[TBL] [Abstract][Full Text] [Related]
3. Special characteristics of atherosclerosis in chronic renal failure.
Amann K; Tyralla K; Gross ML; Eifert T; Adamczak M; Ritz E
Clin Nephrol; 2003 Jul; 60 Suppl 1():S13-21. PubMed ID: 12940530
[TBL] [Abstract][Full Text] [Related]
4. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery disease in chronic kidney disease patients: assessing the evidence for diagnosis, screening and revascularization.
Saw J; Levin A; Gin K
Can J Cardiol; 2004 Jun; 20(8):807-13. PubMed ID: 15229763
[TBL] [Abstract][Full Text] [Related]
6. Management of coronary artery disease in patients with chronic kidney disease.
Coats WC; Baig SZ; Alpert MA; Aggarwal K
Adv Perit Dial; 2009; 25():125-8. PubMed ID: 19886333
[TBL] [Abstract][Full Text] [Related]
7. [Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy].
Cases A; Vera M; López Gómez JM
Nefrologia; 2002; 22 Suppl 1():68-74. PubMed ID: 11987673
[TBL] [Abstract][Full Text] [Related]
8. Renal impairment: a risk factor for ischemic heart disease.
Zoccali C
Curr Opin Pharmacol; 2006 Apr; 6(2):221-5. PubMed ID: 16483843
[TBL] [Abstract][Full Text] [Related]
9. Amino acid and protein metabolism in the human kidney and in patients with chronic kidney disease.
Garibotto G; Sofia A; Saffioti S; Bonanni A; Mannucci I; Verzola D
Clin Nutr; 2010 Aug; 29(4):424-33. PubMed ID: 20207454
[TBL] [Abstract][Full Text] [Related]
10. [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].
Ratto E; Leoncini G; Viazzi F; Pontremoli R
G Ital Nefrol; 2008; 25(1):21-31. PubMed ID: 18264915
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
[TBL] [Abstract][Full Text] [Related]
12. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
[TBL] [Abstract][Full Text] [Related]
13. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.
Kendrick J; Chonchol MB
Nat Clin Pract Nephrol; 2008 Dec; 4(12):672-81. PubMed ID: 18825155
[TBL] [Abstract][Full Text] [Related]
14. Coronary artery disease in patients with renal failure.
Goldsmith DJ; Covic A
Int J Clin Pract; 2001 Apr; 55(3):196-210. PubMed ID: 11351774
[TBL] [Abstract][Full Text] [Related]
15. Prevention of cardiovascular disease in chronic kidney disease patients.
Wanner C
Semin Nephrol; 2009 Jan; 29(1):24-9. PubMed ID: 19121471
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction and chronic kidney disease: treatment options.
Wu-Wong JR
Curr Opin Investig Drugs; 2008 Sep; 9(9):970-82. PubMed ID: 18729004
[TBL] [Abstract][Full Text] [Related]
17. Review article: Coronary artery stenoses: detection and revascularization in renal disease.
Pilmore HL
Nephrology (Carlton); 2009 Sep; 14(6):537-43. PubMed ID: 19712254
[TBL] [Abstract][Full Text] [Related]
18. Anemia, renal transplantation, and the anemia paradox.
Rigatto C
Semin Nephrol; 2006 Jul; 26(4):307-12. PubMed ID: 16949469
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease.
Go AS; Lo JC
Curr Opin Nephrol Hypertens; 2006 May; 15(3):296-302. PubMed ID: 16609298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
